# Healthcare AI Governance Portfolio

This folder contains a practical portfolio starter kit for healthcare AI governance work connected to Ariadne.

The goal is to show that Ariadne is not only an agent scaffold, it is also a controlled environment for building governance artifacts, review workflows, evidence trails, and human approval gates around healthcare AI use cases.

## Intended use

Use these files to document and review AI-enabled healthcare features before they are piloted, enabled, expanded, or monitored in production-like workflows.

This package is designed for examples such as:

- Epic AI features and ambient or generative documentation support
- Draft appeal, prior authorization, and denial-support workflows
- Coding, routing, summarization, inbox, or operational assistant features
- Third-party AI tools proposed for clinical, revenue-cycle, administrative, or patient-facing use

## Portfolio files

| File | Purpose |
| --- | --- |
| `ai-feature-intake.md` | First-pass intake form for an AI feature, vendor tool, or internal AI workflow. |
| `ai-risk-review.md` | Structured risk review aligned to practical healthcare governance concerns. |
| `model-monitoring-and-drift.md` | Monitoring plan for accuracy, safety, workflow fit, user feedback, and drift. |
| `evidence-register.md` | Evidence tracker for approvals, decisions, testing, monitoring, and follow-up. |
| `operating-model.md` | Lightweight operating model for ownership, review cadence, and escalation. |

## Governance principles

1. **Human accountability stays explicit.** AI can assist, but accountable humans own final decisions.
2. **PHI access must be justified.** Any use of patient data requires a defined purpose, minimum necessary access, and approved controls.
3. **Clinical safety outranks productivity.** Time savings do not justify unsafe, biased, misleading, or unreviewed outputs.
4. **Evidence beats assumptions.** Every approval, exception, test result, and monitoring decision should leave an audit trail.
5. **User feedback is a signal, not a formality.** Feedback must be reviewed, triaged, and tied to ownership.
6. **Deployment is not the finish line.** AI features need monitoring for drift, workflow harm, unintended automation bias, and changed vendor behavior.

## Boundaries

These files are portfolio and planning artifacts. They do not authorize:

- Access to PHI
- Production Epic changes
- Automated patient communication
- Credential use
- Vendor approval
- Clinical deployment
- Replacement of legal, privacy, compliance, security, or clinical review

## Suggested workflow

1. Complete `ai-feature-intake.md`.
2. Run the feature through `ai-risk-review.md`.
3. Define monitoring in `model-monitoring-and-drift.md`.
4. Track artifacts and decisions in `evidence-register.md`.
5. Assign owners and escalation paths using `operating-model.md`.
6. Only move forward after the appropriate human review body approves the scope.

## Portfolio positioning

This package is meant to demonstrate healthcare AI governance thinking in a concrete, reviewable form. It is intentionally lightweight, so it can be adapted for internal governance conversations, AIGP study, NIST AI RMF mapping, Epic AI feature review, or future Ariadne governance automation.
